The Structural Rise of VC Secondaries: Liquidity, Discipline and Europe’s Hidden Scale-Up Champions

In this masterclass on venture capital secondaries, Rando Rannus, GP at Siena Secondary Fund, outlines why the traditional 10-year VC model no longer reflects market reality. As companies stay private longer and IPO timelines stretch to 15–20 years, liquidity solutions must evolve.

Siena focuses on secondary investments in high-growth scale-ups across Central and Eastern Europe and the Nordics, targeting category leaders such as Bolt, Oura, Booksy,

and Preply. The strategy centers on providing partial liquidity to early investors, founders, and employees—often enabling them to reinvest into the ecosystem and strengthen Europe’s innovation flywheel.

Rando challenges common misconceptions about VC secondaries, particularly the overemphasis on “average discounts.” Instead, he argues that disciplined underwriting, access to data, cap table analysis, and understanding liquidation preferences are far more critical.

The conversation also explores:

  • Why secondary markets are structurally expanding

  • The downside risk asymmetry compared to early-stage VC

  • Europe’s liquidity inefficiencies vs. the U.S.

  • Estonia’s startup ecosystem and the “Skype moment”

  • The role of pension funds and institutional capital in strengthening venture markets

  • Governance considerations for startups preparing for future liquidity events

Ultimately, this episode positions VC secondaries not as opportunistic arbitrage—but as an essential liquidity infrastructure for a maturing private market.

Blog

Other news you might be also interested in

Analizing The Data Gap with Vestberry: Why Venture Capital's Biggest Blind Spot Is the Portfolio It Already Owns

Marek Zamecnik, Co-CEO of Vestberry, on why portfolio management remains venture capital's most consequential — and least systematised — blind spot.

Rukam Capital — The Gen Z Consumer Revolution in India: A $7.3 Trillion Opportunity

Archana Jahagirdar — Founder and Managing Partner of Rukam Capital — argues that the country’s greatest investment opportunity is no longer technology, but the brands being built for a new generation.

EQT: The Winning Formula for Healthcare Investors in the Age of AI

As private equity adapts to a prolonged high-cost environment, investors are being forced to rethink how they source deals, create value, and deploy capital. Ahead of her appearance at 0100 Europe (April 21–23), we spoke with Geraldine O’Keeffe, Partner at EQT Healthcare Growth, about how one of Europe’s leading investment platforms is transiting today’s market dynamics—across healthcare, technology, and beyond.